切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2014, Vol. 08 ›› Issue (05) : 16 -18. doi: 10.3877/cma. j. issn.1674-0807.2014.05.004

论著

癌基因RhoA 对乳腺癌细胞血管内皮生长因子表达的调控机制研究
赵庆丽1,(), 马骥1   
  1. 1.730050 兰州,中国人民解放军兰州军区兰州总医院乳腺科
  • 收稿日期:2014-01-22 出版日期:2014-10-01
  • 通信作者: 赵庆丽
  • 基金资助:
    国家自然科学基金资助项目(81202085)

Regulatory mechanism of oncogene RhoA on the expression of vascular epithelial growth factor in breast cancer cells

Qingli Zhao1,(), Ji Ma1   

  1. 1.Department of Breast Diseases, Lanzhou General Hospital of PLA, Lanzhou 730000, China
  • Received:2014-01-22 Published:2014-10-01
  • Corresponding author: Qingli Zhao
引用本文:

赵庆丽, 马骥. 癌基因RhoA 对乳腺癌细胞血管内皮生长因子表达的调控机制研究[J]. 中华乳腺病杂志(电子版), 2014, 08(05): 16-18.

Qingli Zhao, Ji Ma. Regulatory mechanism of oncogene RhoA on the expression of vascular epithelial growth factor in breast cancer cells[J]. Chinese Journal of Breast Disease(Electronic Edition), 2014, 08(05): 16-18.

目的

探讨乳腺癌细胞MDA-MB-231 中癌基因RhoA 对VEGF 蛋白表达和胞外分泌的影响及可能的分子机制。

方法

将RhoA 过表达质粒pcDNA3.0-V14RhoA、对照质粒pcDNA3.0、RhoA 沉默质粒pcDNA3.0-shRhoA 转染到MDA-MB-231 细胞中,通过Western blot 和ELISA 实验分别检测细胞内外VEGF 蛋白的表达,通过Western blot 和实时PCR 方法分别检测RhoA 对p53 表达的影响及对VEGF的调控作用。 均数比较用t 检验;计量资料用 表示,采用方差分析。

结果

MDA-MB-231 细胞中上调RhoA 表达后,胞内VEGF 的蛋白表达水平增加;胞外分泌水平显著增加,与对照组相比差异具有统计学意义(F=4.020,P=0.032);MDA-MB-231 细胞中沉默RhoA 表达后,胞内VEGF 的蛋白表达水平降低;胞外分泌水平显著降低,与对照组相比差异具有统计学意义(F=5.131,P=0.001);并且与0 h 相比,在MDA-MB-231 细胞中上调RhoA 可以抑制p53 的表达(48 h:F=3.231,P=0.043),而p53 表达的降低可以增加VEGF 的表达水平(48 h:F=3.226,P=0.015),均差异具有统计学意义。

结论

乳腺癌细胞MDA-MB-231 中RhoA 表达的变化可以引起胞内外VEGF 水平的变化,并且RhoA 可能是通过抑制p53的表达从而增加VEGF 表达。

Objective

To explore the effects of oncogene RhoA on protein expression of vascular epithelial growth factor(VEGF) and exocytosis in breast cancer cell line MDA-MB-231 and its potential molecular mechanism.

Methods

RhoA-overexpressed plasmid pcDNA3.0-V14RhoA, control plasmid pcDNA3.0 and RhoA-silencing plasmid pcDNA3.0-shRhoA were transfected into MDA-MB-231 cells. After that, VEGF protein expression was detected by Western blot and ELISA assay. The effects of RhoA on p53 expression and on VEGF regulation were examined by Western blot or real-time PCR. The means were compared using t text, and the measurement data were expressed as and processed using analysis of variance.

Results

After up-regulating RhoA in MDA-MB-231 cells, intracellular VEGF protein level and extracellular secretion level were significantly increased compared with the control group(F = 4.020,P =0.032), while after down-regulating RhoA in MDA-MB-231 cells, intracellular VEGF protein level and extracellular secretion level were significantly decreased compared with the control group(F = 5.131,P =0.001). Compared with the control group, the upregulation of RhoA could inhibit p53 expression (48 h:F=3.231,P=0.043)and the decrease of p53 expression could promote VEGF expression(48 h:F=3.226,P=0.015).

Conclusion

In breast cancer MDA-MB-231 cells, the change of RhoA expression can cause the change of intracellular and extracellular VEGF expression, and RhoA may promote VEGF expression through inhibiting p53 expression.

[1]
Wang Y, Zheng XR, Riddick N, et al. ROCK isoform regulation of myosin phosphatase and contractility in vascular smooth muscle cells[J]. Circ Res,2009,104(4):531-540.
[2]
Aspenström P, Ruusala A, Pacholsky D. Taking Rho GTPases to the next level:the cellular functions of atypical Rho GTPases[J]. Exp Cell Res,2007,313(17):3673-3679.
[3]
Wu M, Wu ZF, Rosenthal DT, et al. Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers[J]. Cancer,2010,116(11 Suppl):2768-2782.
[4]
Chang CC, Tsai SY, Lin H, et al. Aryl-hydrocarbon receptordependent alteration of FAK/RhoA in the inhibition of HUVEC motility by 3-methylcholanthrene[J]. Cell Mol Life Sci,2009,66(19):3193-3205.
[5]
Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch[J]. Nat Rev Cancer,2003,3(6):401-410.
[6]
Ferrara N. Vascular endothelial growth factor[J]. Arterioscler Thromb Vasc Biol,2009,29(6):789-791.
[7]
Ogata S, Morishige K, Sawada K, et al. Fasudil inhibits lysophosphatidic acid-induced invasiveness of human ovarian cancer cells[J]. Int J Gynecol Cancer,2009,19(9):1473-1480.
[8]
Li H, Peng W, Jian W, et al. ROCK inhibitor fasudil attenuated high glucose-induced MCP-1 and VCAM-1 expression and monocyte-endothelial cell adhesion [ J ].Cardiovasc Diabetol,2012,11:65.
[9]
Quartuccio SM, Lantvit DD, Bosland MC, et al. Conditional inactivation of p53 in mouse ovarian surface epithelium does not alter MIS driven Smad2-dominant negative epithelium-lined inclusion cysts or teratomas[J]. PLoS One, 2013,8(5):e65067
[10]
Zietz C, Rössle M, Haas C, et al. MDM-2 oncoprotein overexpression, p53 gene mutation,and VEGF up-regulation in angiosarcomas[J]. Am J Pathol,1998,153(5):1425-1433.
[11]
Pal S, Datta K, Mukhopadhyay D. Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma[J]. Cancer Res,2001,61(18):6952-6957.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 葛睿, 陈飞, 李杰, 李娟娟, 陈涵. 多基因检测在早期乳腺癌辅助治疗中的应用价值[J]. 中华乳腺病杂志(电子版), 2024, 18(05): 257-263.
[3] 杨柳, 宋振川, 王新乐. 乳腺癌改良根治术联合背阔肌复位的临床疗效评估[J]. 中华乳腺病杂志(电子版), 2024, 18(05): 269-273.
[4] 王睿, 邓俊, 施廷鑫, 张志兆, 王成方, 张毅, 齐晓伟. FAM91A1 可能是乳腺癌患者的独立预后因子[J]. 中华乳腺病杂志(电子版), 2024, 18(05): 274-280.
[5] 季思涵, 唐新宇, 王邦杰, 狄汶洋, 王佳鸣, 查小明, 谢晖, 周文斌, 潘红, 王水. 阿贝西利在激素受体阳性、HER-2 阴性乳腺癌患者中的安全性研究[J]. 中华乳腺病杂志(电子版), 2024, 18(05): 281-286.
[6] 明昊, 肖迎聪, 巨艳, 宋宏萍. 乳腺癌风险预测模型的研究现状[J]. 中华乳腺病杂志(电子版), 2024, 18(05): 287-291.
[7] 王聪, 李云涛, 唐甜甜, 王鑫蕊, 吕鑫, 范志刚. 多基因检测对激素受体阳性、HER-2阴性乳腺癌新辅助化疗疗效预测的研究进展[J]. 中华乳腺病杂志(电子版), 2024, 18(05): 292-296.
[8] 胡文钰, 徐东东, 李南林. 早期乳腺癌全身辅助治疗的研究现状[J]. 中华乳腺病杂志(电子版), 2024, 18(05): 297-303.
[9] 于桐, 孙姗姗, 刘扬. 乳腺导管原位癌的浸润转化机制及临床病理特征[J]. 中华乳腺病杂志(电子版), 2024, 18(05): 304-307.
[10] 潘荔生, 刘忠强, 周莹莹, 陈勃, 李晏宁, 徐金锋, 蔡隆梅, 王宏梅. 乳腺癌内乳淋巴结的诊断和治疗[J]. 中华乳腺病杂志(电子版), 2024, 18(05): 308-314.
[11] 王真真, 谢佳翊, 余涵, 沈雪. 隐匿性乳腺癌子宫转移一例[J]. 中华乳腺病杂志(电子版), 2024, 18(05): 317-319.
[12] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[13] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[14] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[15] 刘虹, 王品, 王彬, 任杰超, 张文杰, 吴剑, 刘莹. 经腋窝腔镜辅助保留乳头乳晕皮下腺体切除术+Ⅰ期胸肌前假体乳房重建术[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 419-422.
阅读次数
全文


摘要